Table 3: Distribution of ERβ and PR in benign and malignant mammary tumors.

Tumor typeERβ+
PR+
ERβ+
PR−
ERβ
PR+
ERβ
PR−
Total

Benign5 (45.45%)4 (36.36%)1 (9.09%)1 (9.09%)11
Malignant6 (33.33%)8 (44.44%)3 (16.67%)1 (5.56%)18

Total11124229